Item 5.07. Submission of Matters to a Vote of Security Holders.
On May 4, 2020, Neon Therapeutics, Inc., a Delaware corporation ("Neon"), held a
virtual special meeting of its stockholders (the "Special Meeting"). Neon's
stockholders voted on Proposal 1 at the Special Meeting, which is described in
more detail in the definitive proxy statement filed by Neon with the Securities
and Exchange Commission on April 2, 2020.
Neon's stockholders were entitled to one vote for each share of common stock,
$0.001 par value per share (each, a "Share"), held as of the close of business
on March 23, 2020 (the "Record Date"). At the close of business on the Record
Date, there were 28,931,978 Shares entitled to vote at the Special Meeting.
Present at the Special Meeting or by proxy were holders of 20,363,853 Shares,
representing 70.38% of the outstanding Shares eligible to vote at the Special
Meeting, and constituting a quorum. The final results with respect to such
proposal are set forth below.
Proposal 1 - The Merger Proposal. To approve and adopt the Agreement and Plan of
Merger, dated as of January 15, 2020, or as amended, modified or otherwise
supplemented from time to time (the "Merger Agreement"), by and among Neon,
BioNTech SE, a Societas Europaea organized and existing under the laws of
Germany ("BioNTech"), and Endor Lights, Inc., a Delaware corporation and a
direct, wholly-owned subsidiary of BioNTech:
 Votes For    Votes Against    Abstentions
19,696,223           73,646        593,984

Stockholder action on a second proposal, to approve the adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies in favor of approving the Merger Proposal, was not required and no vote was taken on that proposal. --------------------------------------------------------------------------------


                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses